SYNERGY PHARMACEUTICALS, INC.
CIK 0001347613
Revenue (TTM)
—
Q3 Nov 2018
Net Income (TTM)
—
Q3 Nov 2018
EPS Diluted (TTM)
—
Q3 Nov 2018
Gross Margin
—
Q3 Nov 2018
Operating Margin
—
Q3 Nov 2018
Net Margin
—
Q3 Nov 2018
Free Cash Flow (TTM)
−$114.98M
Q3 Nov 2018
Cash
$45.65M
Q3 Nov 2018
Total Debt
$100.33M
Q3 Nov 2018
Shares Outstanding
248.04M sh
Q3 Nov 2018